KeyPlants to extend leadership in offsite construction for the life science industry with the acquisition of the assets in Swedish Modules, our modular workshop partner with more than 45 years of experience delivering more than 3,500 modules to over 30 countries.
Stockholm, Sweden, October 12, 2021
KeyPlants, a leading global provider of modular facilities for medicines, including biologics, and cell and gene therapy, today announced that it has reached an agreement to acquire Swedish Modules, a workshop specializing in delivery of prefabricated, high-specification modular solutions.
Our long-term partner, Swedish Modules have more than 45 years of experience in prefabrication and has delivered over 3,500 high-specification modules to more than 30 countries. From now on, the workshop will be fully integrated into the supply chain, from engineering, fabrication and delivery through a qualified facility.
The acquisition will strengthen KeyPlants’ modular workshop capabilities and support our mission to offer standardized as well as customized process integrated facility solutions. The workshop in Vara, Sweden, 100 km from Gothenburg, has the capacity to manufacture more than 20,000 m2 of cleanroom space per year.
“This acquisition allows us to further reduce the delivery time in our projects and to provide improved quality and reliability to our customers as well as to supply standard POD cleanroom space on demand.
The colleagues in the workshop have unrivalled experience and expertise when it comes to modular fabrication and we are delighted to welcome them to our team” commented Jörgen Harrysson, Managing Director at KeyPlants. “This is a strategic acquisition for KeyPlants, supporting our vision to be the leading provider of innovative life science facilities.”
The combination will unlock significant commercial synergies as KeyPlants brings the unique offerings of each company to their respective high-quality customer bases. The acquisition will also ensure that KeyPlants remain the fastest provider of turnkey modular facilities to the life science industry.